Disturbances of sleep and wake are among the most common and disabling nonmotor manifestations of Parkinson disease (PD), affecting as many as 90% of patients.
1,2 Disrupted sleep-wake cycles contribute to poor quality of life and increased risk for accidents, leading to increased morbidity and mortality in the PD population.
3-5 Current treatment options for disturbed sleep and alertness in PD are very limited and are associated with undesirable adverse effects. Therefore, the need to understand the mechanisms leading to sleep-wake dysfunction in PD and to develop innovative treatment modalities is great. The exact pathophysiological features of sleep-wake disturbances in PD remain largely unknown, but the cause is likely to be multifactorial, including the effect of motor symptoms on sleep, primary sleep disorders (sleep apnea and Rapid Eye Movement Sleep Behavior Disorder), adverse effects of medications, and neurodegeneration of central sleep-wake regulatory systems.
6-9